Medicine Supply Notification: Suprefact and Suprecur

Department of Health and Social Care (DHSC) has issued a medicine supply notification for:

  • Buserelin (Suprefact®) 5.5mg/5.5ml solution for injection vials
  • Buserelin (Suprecur®) 5.5mg/5.5ml solution for injection vials 
  • Buserelin (Suprecur®) 150microgram/dose nasal spray

MSN/2022/061

Tier 2 – medium impact

Date of issue 11th July 2022

  • Buserelin (Suprefact®) 5.5mg/5.5ml solution for injection vials are out of stock until mid-August 2022. Limited supply remains available in NHS Trusts and health boards.
  • Buserelin (Suprecur®) 5.5mg/5.5ml solution for injection vials are currently available, however, this stock is short dated (expires end of July) and further stock is expected mid-August 2022.
  • Buserelin (Suprecur®)150microgram/dose nasal spray is out of stock until late-December 2022. Limited supply remains available in NHS Trusts and Health Boards.
  • Nafarelin (Synarel®) 200microgram/dose nasal spray remains available but is currently unable to support an uplift in demand (until mid-August 2022 when it can support a partial uplift in demand).
  • Alternative gonadotrophin-releasing hormone (GnRH) analogues (parenteral formulations) remain available.

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Support the call for more funding by recording information about the informal advice you provide to patients over just one day.

Click Here